Navigate through the intricacies of Novavax with our comprehensive report here. NasdaqGS:NVAX Revenue & Expenses Breakdown as at Mar 2025 Over the last year, Novavax achieved a total shareholder ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

As of 10:20:05 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Novavax (NVAX) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $1.44 per share a year ago. These figures are ...

Novavax (NASDAQ:NVAX), a biotechnology company focused on vaccine development, released its financial results for the fourth quarter and full year of 2024 today. The company reported fourth-quarter ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported a loss of $81 million in its fourth quarter. On a per-share basis, the Gaithersburg, Maryland-based ...

IWATA, February 25, 2025 - Yamaha Motor Co., Ltd. has agreed to acquire New Zealand-based startup Robotics Plus, which specializes in agricultural automation solutions. Closing is scheduled to occur ...

As of 21 February at 15:59:48 GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.